The United States Food and Drug Administration recently approved Elelyso, the first drug to be grown in genetically modified plant cells. Produced in carrot cells, this drug helps to treat the symptoms of Gaucher disease, a genetic disorder that causes bruising, anemia and low blood platelets.
Israeli scientists were able to insert a gene that codes for a human enzyme into carrot cells, causing the cells to produce the same protein that Gaucher patients lack. This new method should help prevent drug shortages that have affected Gaucher sufferers in the past, as well as being cheaper and less prone to infection than animal cells. Soon mothers may be telling their children to eat carrots, not just for better eyesight, but for better health across the board.